Related Experiment Video
Updated: Apr 28, 2026
03:25
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
8.0K
Skin and adhesive issues with continuous glucose monitors: a sticky situation
Kimberly Englert1, Katrina Ruedy2, Julie Coffey3
1Nemours Children's Clinic, Pediatric Endocrinology, Jacksonville, FL, USA.
Journal of Diabetes Science and Technology
|May 31, 2014
Summary
Continuous glucose monitoring (CGM) in young children with type 1 diabetes (T1D) faces challenges like skin irritation and sensor adhesion. Using supplemental products can improve wear duration and tolerability for better T1D management.
Area of Science:
- Pediatric Endocrinology
- Biomedical Engineering
- Diabetes Technology
Background:
- Type 1 diabetes (T1D) management in young children requires reliable glucose monitoring.
- Continuous Glucose Monitoring (CGM) offers significant benefits but presents unique challenges in pediatric populations.
- Adolescent and pediatric diabetes care necessitates adaptive technologies for effective disease management.
Purpose of the Study:
- To identify challenges in using CGM devices in children aged 1-9 with T1D.
- To describe techniques and products that enhance CGM sensor wear duration and adherence.
- To improve the overall tolerability and effectiveness of CGM for young children with T1D.
Main Methods:
- Two studies involving 169 children with T1D (ages 1-9) were conducted.
- Children were instructed in the daily use of CGM devices.
- Various commercially available products and techniques were employed to address skin irritation and sensor adhesion issues.
Main Results:
- Key challenges included limited body surface area, environmental factors (temperature, humidity), and physical activity.
- Supplemental products and techniques successfully reduced skin irritation and improved CGM sensor adhesion.
- Optimized adhesion and minimized skin irritation led to increased CGM use duration and better tolerability.
Conclusions:
- Addressing skin irritation and sensor adhesion is critical for successful CGM use in young children with T1D.
- Tailored techniques and supplemental products can overcome common challenges, improving device adherence.
- Improving CGM tolerability and wear duration is essential for effective diabetes management in pediatric patients.
Related Concept Videos
01:22Complications of Diabetes Mellitus
17
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
17
01:29Hyperglycemia
24
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
24
01:19Type I Diabetes III: Clinical Manifestations
21
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
21
01:15Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:31Diabetic Foot Ulcer
29
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
29